Division of Infection and Immunity, University College London, Windeyer Institute, London, UK.
Immunology. 2011 Jan;132(1):27-38. doi: 10.1111/j.1365-2567.2010.03334.x. Epub 2010 Aug 25.
The immune response to human cytomegalovirus (HCMV) infection is characterized by the accumulation of HCMV-specific CD8(+) T cells, particularly in the elderly; such expansions may impair immune responses to other pathogens. We investigated mechanisms underlying HCMV-specific expansions in 12 young and 21 old healthy subjects (although not all analyses were performed on all subjects). Phenotypically, HCMV-pentamer(+) CD8(+) T cells were characterized by marked Vβ restriction, advanced differentiation (being predominantly CD27(-) CD28(-) ), and variable CD45RO/RA expression. Although more common and larger in older subjects, expansions had similar phenotypic characteristics in the young. In one old subject, repeated studies demonstrated stability in size and Vβ distribution of pentamer(+) populations over 6 years. We tested whether HCMV-specific CD8(+) T-cell expansions arose from accelerated proliferation or extended lifespan by in vivo labelling with deuterated glucose and ex vivo Ki-67 expression. Uptake of deuterated glucose was lower in pentamer(+) cells than in pentamer(-) CD8(+) CD45RO(+) or CD8(+) CD45RA(+) cells in three old subjects, consistent with reduced proliferation and extended lifespan. Similarly Ki-67 labelling showed no evidence for increased proliferation in HCMV-specific CD8(+) expansions in older subjects, although pentamer(-) CD45RA(+) cells from young donors expressed very little Ki-67. We investigated Bcl-2 and CD95 as possible anti-apoptotic mediators, but neither was associated with pentamer-positivity. To investigate whether expansion represents a compensatory response to impaired functionality, we performed two tests of functionality, peptide-stimulated proliferation and CD107 expression; both were intact in pentamer(+) cells. Our data suggest that HCMV-specific CD8(+) expansions in older subjects accumulate by extended lifespan, rather than accelerated proliferation.
人类巨细胞病毒 (HCMV) 感染的免疫反应表现为 HCMV 特异性 CD8(+) T 细胞的积累,特别是在老年人中;这种扩增可能会损害对其他病原体的免疫反应。我们研究了 12 名年轻和 21 名健康老年人(尽管并非所有分析都在所有受试者上进行)中 HCMV 特异性扩增的机制。表型上,HCMV-五聚体(+) CD8(+) T 细胞表现出明显的 Vβ 限制、分化程度高(主要是 CD27(-) CD28(-))和可变的 CD45RO/RA 表达。尽管在老年人中更为常见和更大,但在年轻人中,扩增具有相似的表型特征。在一名老年人中,重复研究表明,在 6 年内,五聚体(+)群体的大小和 Vβ 分布保持稳定。我们通过体内氘葡萄糖标记和体外 Ki-67 表达来测试 HCMV 特异性 CD8(+) T 细胞扩增是否来自加速增殖或延长寿命。在 3 名老年人中,与五聚体(-) CD8(+) CD45RO(+)或 CD8(+) CD45RA(+)细胞相比,五聚体(+)细胞摄取氘葡萄糖的水平较低,这与增殖减少和寿命延长一致。同样,Ki-67 标记在老年人的 HCMV 特异性 CD8(+)扩增中没有显示出增殖增加的证据,尽管来自年轻供体的五聚体(-) CD45RA(+)细胞表达很少的 Ki-67。我们研究了 Bcl-2 和 CD95 作为可能的抗凋亡介质,但两者都与五聚体阳性无关。为了研究扩张是否代表对功能受损的代偿反应,我们进行了两项功能测试,即肽刺激增殖和 CD107 表达;两者在五聚体(+)细胞中均完好无损。我们的数据表明,老年人中 HCMV 特异性 CD8(+) 扩增是通过延长寿命而不是加速增殖来积累的。